Logo image of JYNT

JOINT CORP/THE (JYNT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:JYNT - US47973J1025 - Common Stock

8.7 USD
+0.06 (+0.69%)
Last: 12/9/2025, 11:25:48 AM
Fundamental Rating

4

Taking everything into account, JYNT scores 4 out of 10 in our fundamental rating. JYNT was compared to 100 industry peers in the Health Care Providers & Services industry. The financial health of JYNT is average, but there are quite some concerns on its profitability. JYNT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

JYNT had negative earnings in the past year.
In the past year JYNT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: JYNT reported negative net income in multiple years.
In the past 5 years JYNT always reported a positive cash flow from operatings.
JYNT Yearly Net Income VS EBIT VS OCF VS FCFJYNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

JYNT has a Return On Assets (-1.40%) which is comparable to the rest of the industry.
With a Return On Equity value of -4.27%, JYNT perfoms like the industry average, outperforming 47.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.4%
ROE -4.27%
ROIC N/A
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
JYNT Yearly ROA, ROE, ROICJYNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

JYNT has a better Gross Margin (78.26%) than 93.00% of its industry peers.
In the last couple of years the Gross Margin of JYNT has declined.
The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
JYNT Yearly Profit, Operating, Gross MarginsJYNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

6

2. Health

2.1 Basic Checks

JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JYNT has more shares outstanding
JYNT has more shares outstanding than it did 5 years ago.
JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JYNT Yearly Shares OutstandingJYNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
JYNT Yearly Total Debt VS Total AssetsJYNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

JYNT has an Altman-Z score of 2.76. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of JYNT (2.76) is comparable to the rest of the industry.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.76
ROIC/WACCN/A
WACC8.75%
JYNT Yearly LT Debt VS Equity VS FCFJYNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
JYNT has a Current ratio of 1.83. This is in the better half of the industry: JYNT outperforms 72.00% of its industry peers.
A Quick Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.83, JYNT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
JYNT Yearly Current Assets VS Current LiabilitesJYNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.03% over the past year.
The Revenue for JYNT has decreased by -24.15% in the past year. This is quite bad
Measured over the past years, JYNT shows a small growth in Revenue. The Revenue has been growing by 1.36% on average per year.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%

3.2 Future

Based on estimates for the next years, JYNT will show a very strong growth in Earnings Per Share. The EPS will grow by 44.54% on average per year.
Based on estimates for the next years, JYNT will show a very negative growth in Revenue. The Revenue will decrease by -22.13% on average per year.
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JYNT Yearly Revenue VS EstimatesJYNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
JYNT Yearly EPS VS EstimatesJYNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

4

4. Valuation

4.1 Price/Earnings Ratio

JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 17.89, the valuation of JYNT can be described as rather expensive.
Based on the Price/Forward Earnings ratio, JYNT is valued a bit cheaper than the industry average as 66.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of JYNT to the average of the S&P500 Index (23.56), we can say JYNT is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 17.89
JYNT Price Earnings VS Forward Price EarningsJYNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of JYNT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 79.25
EV/EBITDA N/A
JYNT Per share dataJYNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JYNT's earnings are expected to grow with 44.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y105.18%
EPS Next 3Y44.54%

0

5. Dividend

5.1 Amount

JYNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JOINT CORP/THE

NASDAQ:JYNT (12/9/2025, 11:25:48 AM)

8.7

+0.06 (+0.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners78.62%
Inst Owner Change-1.63%
Ins Owners22.81%
Ins Owner Change2.31%
Market Cap129.37M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76.36
Price Target10.97 (26.09%)
Short Float %5.03%
Short Ratio5.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)-27.73%
PT rev (3m)-27.73%
EPS NQ rev (1m)-54.29%
EPS NQ rev (3m)-46.67%
EPS NY rev (1m)-1200%
EPS NY rev (3m)-550%
Revenue NQ rev (1m)-5.58%
Revenue NQ rev (3m)-5.89%
Revenue NY rev (1m)-1.47%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.89
P/S 1.41
P/FCF 79.25
P/OCF 42.12
P/B 5.7
P/tB 5.7
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0.49
Fwd EY5.59%
FCF(TTM)0.11
FCFY1.26%
OCF(TTM)0.21
OCFY2.37%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.4%
ROE -4.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.26%
FCFM 1.78%
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 78.79%
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 2.76
F-Score6
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year311.08%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%

JOINT CORP/THE / JYNT FAQ

What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to JYNT.


What is the valuation status for JYNT stock?

ChartMill assigns a valuation rating of 4 / 10 to JOINT CORP/THE (JYNT). This can be considered as Fairly Valued.


How profitable is JOINT CORP/THE (JYNT) stock?

JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for JYNT stock?

The Earnings per Share (EPS) of JOINT CORP/THE (JYNT) is expected to grow by 84.93% in the next year.